2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-3ÀÏ : 2024-03-30 |
|
2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-3ÀÏ : 2024-03-30 ±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-3ÀÏ ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ À̸ÞÀÏ : hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú Âü¼®¿¹»óÀÎ : 500¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 300,000¿ø ºñ°í "2¿ù 28ÀϱîÁö ȸ¿ø 100,000¿ø / ºñȸ¿ø 200,000¿ø 3¿ù 1ÀϺÎÅÍ È¸¿ø 200,000¿ø / ºñȸ¿ø 300,000¿ø"
±³À°½Ã°£ 03¿ù 30ÀÏ ROOM1 09:00~09:25 Functional iron deficiency in cancer patients Ik-Chan Song(Chungnam National University Korea) ±³À°½Ã°£ 03¿ù 30ÀÏ ROOM1 09:25~09:50 Assessment of neutropenia in hospitalized patients Young Hoon Park(Ewha Womans University Korea) ±³À°½Ã°£ 03¿ù 30ÀÏ ROOM1 09:50~10:15 Perioperative consultation for the appropriate transfusion Ka-Won Kang(Korea University Korea) ±³À°½Ã°£ 03¿ù 30ÀÏ ROOM1 10:30~11:15 Carfilzomib, lenalidomide, dexamethasone in the real-world Asian relapsed and/or refractory multiple myeloma patients - KMM2201 study Ji Hyun Lee(Dong-A University Korea)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 1 , Á¶È¸¼ö : 564 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 592 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 443 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 561 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,108 , ´ñ±Û¼ö : 0 |